Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,976 | 45,660 | 56,075 | N/A | N/A |
| Marketable Securities | 235,328 | N/A | N/A | N/A | N/A |
| TOTAL | $313,750 | $47,104 | $56,334 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 6,356 | 125 | 84 | N/A | N/A |
| Other Non-Current Assets | 1,859 | 263 | 49 | 0 | 0 |
| TOTAL | $8,215 | $388 | $133 | $N/A | $N/A |
| Total Assets | $321,965 | $47,492 | $56,467 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,918 | 1,218 | 212 | 0 | 0 |
| Accrued Expenses | 31,418 | 16,212 | 2,090 | N/A | N/A |
| Other current liabilities | 218 | N/A | N/A | N/A | N/A |
| TOTAL | $42,554 | $17,430 | $2,302 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 144 | 0 | 0 | 0 | 0 |
| TOTAL | $144 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $42,698 | $17,430 | $2,302 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 13 | 1 | 1 | N/A | N/A |
| Retained earnings | -194,225 | -90,998 | -26,125 | N/A | N/A |
| Other shareholders' equity | -4 | 119,770 | 79,897 | 0 | 0 |
| TOTAL | $279,267 | $30,062 | $54,165 | $N/A | $N/A |
| Total Liabilities And Equity | $321,965 | $47,492 | $56,467 | $0 | $0 |